Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome

Title
Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
Authors
Keywords
-
Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2008-08-07
DOI
10.1097/dbp.0b013e31817dc447

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started